Brahmi extract (Centalla asiatica) (CAS NO : 93165-26-1)

Brahmi extract (CAS 84696-21-9), derived from Centella asiatica, is increasingly integrated into the high purity fine chemicals sector as a botanical pharmaceutical intermediate, where American CDMOs utilize its triterpenoid saponins to develop cognitive-enhancing nutraceuticals and dermatological therapeutics. Gotu Kola extract has emerged as a high-demand priority for bulk chemical supplier networks in the United States, driven by a strategic pivot toward sustainable, plant-based active ingredients that meet rigorous FDA and DSHEA regulatory compliance frameworks for clean-label consumer goods. Centella asiatica extract remains a vital substrate for custom synthesis services specializing in standardized bio-actives, where maintaining precise asiaticoside and madecassoside concentrations through HPLC and MS analysis is critical for ensuring batch-to-batch efficacy in advanced wound-healing applications. We are an established Brahmi extract intermediates supplier with Brahmi extract >= 99% purity in the american region, ensuring minimal carry-over of impurities in the final API, and a broad range of various pharmaceutical intermediates for API manufacturers and finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting Brahmi extract COA/TDS/SDS region-specific regulatory support, reliable lead times, united states nationwide supply chain capabilities.